The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
AirSculpt Technologies 14-Day RSI Related Terms
AIRS vs AUNA, CCRN, SRTA: 14-Day RSI Comparison
For the Medical Care Facilities subindustry, AirSculpt Technologies's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AirSculpt Technologies 14-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where AirSculpt Technologies's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AirSculpt Technologies (AIRS) has a 14-Day RSI of 42.90 as of Jul. 12, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on AirSculpt Technologies and its competitors. According to the industry distribution chart, AirSculpt Technologies ranks #185 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 26.5%.
Is AirSculpt Technologies' 14-Day RSI too high?
AirSculpt Technologies' current 14-Day RSI is 42.90. The Healthcare Providers & Services industry median 14-Day RSI is 50.73. AirSculpt Technologies' value of 42.90 is 15.4% below this industry median. Based on the distribution chart, AirSculpt Technologies ranks #185 out of 698 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, AirSculpt Technologies has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AirSculpt Technologies' 14-Day RSI compare to AUNA and CCRN?
According to the Healthcare Providers & Services industry distribution chart, AirSculpt Technologies ranks #185 out of 698 companies for 14-Day RSI. This puts AirSculpt Technologies in the upper half of its industry. The industry median 14-Day RSI is 50.73. AirSculpt Technologies' value of 42.90 is 15.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 50.73, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AirSculpt Technologies's current 14-Day RSI of 42.90 is 15.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on AirSculpt Technologies and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 50.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AirSculpt Technologies's current 14-Day RSI is 42.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AirSculpt Technologies stock overvalued right now?
Based on GuruFocus' analysis, AirSculpt Technologies (AIRS) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.90, compared to a current price of $4.33 — trading 11% above its estimated fair value. The current 14-Day RSI is 42.90 and 15.4% below the Healthcare Providers & Services industry median of 50.73. AirSculpt Technologies' overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For AirSculpt Technologies (AIRS), the current 14-Day RSI is 42.90 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AirSculpt Technologies (AIRS) Overvalued in 2026?
Based on GuruFocus' analysis, AirSculpt Technologies stock appears to be overvalued.
The current stock price of $4.33 is trading 11% above its estimated GF Value™ of $3.90.
GuruFocus considers AirSculpt Technologies to be Modestly Overvalued.
Key valuation signals for AIRS:
14-Day RSI: 42.90
GF Value™: $3.90 vs. price of $4.33 (11% above fair value)
Industry Position: 15.4% below the Healthcare Providers & Services median (#185 of 698)
No single metric tells the full story. See the AIRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
74GF Score
Get the complete analysis for AIRS
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRS has been successfully added to your 